ClinicalTrials.gg
Drug

Amodiaquine clinical trials

studies test it
63
open now
4
in phase 3
20
first study started
2001

Counted the way a researcher would: Amodiaquine with its salts, dosage forms, brands and biosimilars. Looking for a trial to join? Including related medicines shows more you could take part in.

This browser remembers your choice.

How each study uses Amodiaquine is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Amodiaquine studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
Not in FDA's approval records
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Amodiaquine
12
AQ
2
Camoquin
2

In one entry with another drug

Given together, or one or the other

Artesunate-amodiaquine
11
SPAQ
7
Artesunate + Amodiaquine
6
ASAQ
5
sulfadoxine-pyrimethamine plus amodiaquine
3
ASAQ Winthrop®
2
ASAQ, Coarsucam
2
amodiaquine plus artesunate
2

Studies by the year they started

63 studies that test it; most in 2005 (6)

Studies that test Amodiaquine, by start year
YearStudies
20012
20033
20042
20056
20064
20073
20085
20093
20103
20112
20125
20131
20141
20152
20162
20171
20191
20203
20212
20226
20232
20243
20261

By phase

A phase 1/2 study counts in both.

Phase 1
8
Phase 2
11
Phase 3
20
Phase 4
26
No phase
2

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 8 · Other 55

London School of Hygiene and Tropical Medicine (16) · Malaria Consortium (5) · University of Oxford (4) · Centre Muraz (4) · Sanofi (4) · Ministry of Public Health, Democratic Republic of the Congo (3) · Centers for Disease Control and Prevention (3) · University of California, San Francisco (2)

Often tested with

Tested in the same studies.

Artesunate (32) · Fanasil, pyrimethamine drug combination (21) · Artemether, Lumefantrine Drug Combination (17) · Artenimol (9) · Piperaquine (9) · Chloroquine (5) · Primaquine (4) · Sulfadoxine (4)

Studies

Open first, then newest update. How each study uses Amodiaquine is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 63

See all 63 studies that test Amodiaquine →

Given beside what is tested · 3 — Amodiaquine is usual care or a partner of the new treatment
As the comparator · 5 — what is tested is compared with Amodiaquine

Codes

What other systems call Amodiaquine · ClinicalTrials.gg INT006960

  • MeSH (NLM) D000655AmodiaquineConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 220236ED28AMODIAQUINEConfirmed FDA, NLM, Wikidata
  • RxNorm 720Confirmed FDA, Wikidata
  • Wikidata Q239569amodiaquineConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C65231AmodiaquineOne source FDA
  • DrugBank DB00613One source Wikidata

Also registered as amodiaquine hydrochloride (UNII K6PW2S574L · RxNorm 314495).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.